Performance of the TCu380A and Cu-FIX IUDs in an international randomized trial

Contraception

Volumn 53, Issue 4, 1996, Pages 197-203

  Rosenberg, Michael J ^a,f   Foldesy, Robin ^b   Mishell Jr , Daniel R ^c   Speroff, Leon ^d   Waugh, Michael S ^a   Burkman, Ronald ^e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Gynopharma Inc   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e Baystate Med Cent   (United States)

^f Health Decisions Inc   (United States)

Author keywords

contraceptive; discontinuation; IUD; pelvic inflammatory disease

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; NORMAL HUMAN; PELVIC INFLAMMATORY DISEASE; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029993725     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00036-4     Document Type: Article

References (18)

1. Trussell JE, Hatcher RA, Cates W, Stewart FH, Kost K. Contraceptive failure in the United States: An update. Stud Fam Plann 1990;21:51-4.
2. Sivin I, Greenslade F, Schmidt F, Waldman SN. The Copper T380 Intrauterine Device. New York: The Population Council, 1992.
3. Wildemeersch D, Van der Pas H, Thiery M. The Copper-Fix (Cu-Fix): A new concept in IUD technology. Adv Contraception 1988;4:197-205.
4. Batar I. One-year clinical experience with Flexigard. Contraception 1992;46:307-12.
5. Wildemeersch D. The FlexiGard® 330. In: Bardin CW, Mishell DR, eds. Proceedings of the Fourth International Conference on IUDs. Boston:Butterworth-Heinemann, 1994:273-83.
6. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785-8.
7. Walsh TL, Bernstein GS, Grimes DA, Frezieres R, et al. Effect of prophylactic antibiotics on morbidity associated with IUD insertion: results of a pilot randomized controlled trial. Contraception 1994;50:319-27.
8. Eschenbach DA. Earth, motherhood, and the intrauterine device. Fertil Steril 1992;57:1177-9.
9. Grimes DA. The intrauterine device, pelvic inflammatory disease, and infertility: The confusion between hypothesis and knowledge. Fertil Steril 1992;58:670-3.
10. Rosenberg MJ. Flak jacket for editors. Fertil Steril 1993;60:189-90.
11. Tietze C, Lewit S. Recommended procedures for the statistical evaluation of intrauterine contraception. Fam Plann Perspect 1973;4:35-42.
12. Potter RG. Use-effectiveness of intrauterine contraception as a problem in competing risks. In: Freedman R, Takeshita JY, eds. Family Planning in Taiwan. Princeton, NJ: University Press, 1969:485.
13. Azen SP, Roy S, Pick MC, Casagrande J, Mishell Jr DR. A new procedure for statistical evaluation of intrauterine contraception. Am J Obstet Gynecol 1977; 128:329-35.
14. Sivin I, Stem J. Long-acting, more effective Copper T IUDs: A summary of U.S. experience, 1970-75. Stud Fam Plann 1979;10:263.
15. Special Programme of Research, Development, and Research Training in Human Reproduction. Annual Technical Report, 1992. Geneva: World Health Organization, 1993.
16. Harlap S, Kost K, Forrest JD. Preventing pregnancy, protecting health: a new look at birth control choices in the United States. New York: Alan Guttmacher Institute, 1991.
17. Hatcher RA, Stewart F, Trussell J, et al., eds. Contraceptive Technology: Sixteenth Revised Edition. New York: Irvington Publishers, 1994.
18. Jones E, Forrest J. Contraceptive failure rates based on the 1988 NSFG. Fam Plann Perspect 1990;24:12-19.